Product Technology. Ownership of all patentable inventions discovered in the course of the Research Collaboration that constitute Product Technology (specifically including, but not limited to composition of matter claims to Alliance Genes) shall be solely determined based on comparative relevance to the Biosource Field and the TDCC Field. The parties shall have an obligation to assign rights to each other as follows: (i) Biosource shall solely own all patentable inventions discovered in the course of the Research Collaboration that constitute Product Technology, where the sole use of the Product Technology is in the Biosource Field; provided, however, that any development of inventions in the Biosource Field shall not be part of Research Services. In the event that one or more employees of TDCC or DAS is an inventor of such an invention, TDCC or DAS, as appropriate, shall cause such employees to assign all of his/her rights in such invention, including all intellectual property rights therein, to Biosource; (ii) TDCC shall solely own all patentable inventions discovered in the course of the Research Collaboration that constitute Product Technology, where the sole use of the Product Technology is in the TDCC Field, or relate to genes, nucleotide sequences or fragments thereof of Photorhabdus, Xenorhabdus, Bacillus thuringiensis, and Saccharopolyspora spinxxx xx Demeter Genes. In the event that one or more employees of Biosource is an inventor of such an invention, Biosource shall cause such employee(s) to assign all of his/her rights in such invention, including all intellectual property rights therein, to TDCC; (iii) where patentable inventions are discovered in the course of the Research Collaboration that constitute Product Technology that have uses in both the Biosource Field and TDCC Field, the invention shall be Owned solely by TDCC. In the event that one or more employees of a party is an inventor of such a patentable invention Owned by another party under this Section 7.1.1(c), the party shall cause such employee(s) to assign all of his/her rights in such invention, including all intellectual property rights therein, to the party having ownership hereunder .
Product Technology. As between the Parties, Licensee shall own and, subject to the licenses and rights of reference granted in Article 3, retain all right, title and interest in and to any and all Product Technology. MTI will, and does hereby, assign to Licensee and will cause each of its officers, directors, employees, Affiliates, subcontractors and agents to assign to Licensee all such right, title and interest in and to any Product Technology, without additional compensation, as is necessary to fully effect the sole ownership provided for in the first sentence of this Section 10.2.3.
Product Technology. (a) Notwithstanding the terms of Sections 10.1, 10.2, and 10.3, any Joint Technology or VIT Technology directly related to the Compound or Product and arising directly from the Development of the Compound or Product under this Agreement that directly relates to (i) a pharmaceutical product with the same or similar chemical composition, formulation and mode of delivery of the Product, (ii) a pharmaceutical composition comprising the API of the Product, (iii) any amendment, change or improvement to the manufacturing process or specifications for the Product provided by ChemoCentryx to VIT, (iv) a new medical use of or method of using the Product (other than treatment algorithms or patient care programs), and (v) any combination of the API of the Product that includes at least one additional API other than the API of the Product (the “Product Technology”)), shall be the exclusive property of ChemoCentryx and the corresponding intellectual property rights shall be owned by ChemoCentryx.
Product Technology. As between the Parties, HemoSense owns and shall continue to own all right, title and interest (including all patent and other intellectual-property rights) in and to (i) Coagulation Cocktail 2 and (ii) any inventions made by a Party or the Parties in connection with the performance of this Agreement or in connection with the development or manufacture of Coagulation Cocktail 2 prior to the date of this Agreement that primarily relate to Coagulation Cocktail 2 or constitute improvements to Coagulation Cocktail 2 (collectively, the “Product Technology”). Product Technology includes, but is not limited to, the compositions, formulations, recipes and specifications for Coagulation Cocktail 2.
Product Technology. 2.1.1 Siemens shall provide GateField with the Design Information Package for each Product Technology as more fully described in Exhibit 2 for the purpose of specifying the Product Technology related design requirements for establishing the Product Information Package in accordance with Section 2.1.2. GateField shall be entitled to use the Design Information Package to develop and design the Integrated Circuit Products.
Product Technology. Perrigo shall solely own all right, title and interest in and to the Product Technology. Sol-Gel hereby assigns to Perrigo all of its right, title and interest in and to the Product Technology. Sol-Gel shall perform, during and after the Term, all acts that Perrigo reasonably deems necessary or desirable to permit and assist Perrigo, at Pxxxxxx’x expense, in obtaining, perfecting and enforcing the full benefits, enjoyment, rights and title throughout the world in the Product Technology. Perrigo shall have the world-wide right to control the drafting, filing, prosecution, maintenance and enforcement of patents covering the Product Technology and shall be fully responsible for related costs.
Product Technology. Licensee shall be and remain the sole and exclusive owner of all rights, title and interest on a worldwide basis in and to the Product Technology (including the Product Patents), and, for that purpose, Licensor hereby assigns, and Licensor shall cause its Affiliates, employees, consultants, and agents to assign, its right, title, and interest in and to all Product Technology (including the Product Patents) to Licensee.
Product Technology. For the use, the term (as hereinafter defined), in the Territory (as hereinafter defined), and on the terms and conditions hereinafter set forth, Licensor also hereby grants to Licensee the right to use, and Licensee undertakes to use, the Product Technology to manufacture and sell the Product.
Product Technology. Licensee shall manufacture, distribute, market, and sell the Product and products made from the accepted Additional Technology/Non Trademark Technology in accordance with the specifications, directions, and processes furnished to the Licensee by the Licensor from time to time. The quality of the Product and products made from the accepted Additional Technology as manufactured by the Licensee shall be satisfactory to the Licensor or as specified by it or approved by it.
Product Technology. Xxxxx may disclose TALi Confidential Information comprising (whether in whole or in part) Product Technology only:
